文献速递甲状腺疾病

深度测序连锁位点识别家族性自身免疫甲状腺疾病新罕见变异

Identification of New Rare Variants Associated With Familial Autoimmune Thyroid Diseases by Deep Sequencing of Linked Loci.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

本研究对34个家族性自身免疫甲状腺疾病(AITD)家系中先前定位的3个连锁位点(10q、12q、14q)进行深度测序,旨在发现与家族性AITD相关的新罕见变异。结果鉴定出13个位于IPMK基因的罕见变异与AITD(Graves病和桥本甲状腺炎)相关,2个位于DLST和ZFYVE1基因的罕见变异仅与Graves病相关,3个位于PGAM1P5、LOC105369879和METAP2基因的罕见变异仅与桥本甲状腺炎相关。结论表明罕见变异也贡献于AITD遗传易感性,并识别出6个AITD易感基因中的新罕见变异。

要点

  • 罕见变异与常见变异共同贡献家族性AITD遗传易感性。
  • IPMK基因13个罕见变异与AITD(Graves病和桥本甲状腺炎)相关。
  • DLST/ZFYVE1变异仅与Graves病相关,PGAM1P5/LOC105369879/METAP2变异仅与桥本甲状腺炎相关。

核心结论

  • 罕见变异与常见变异共同贡献于AITD遗传易感性。
  • 在6个AITD易感基因中识别出新的罕见变异, predispose to familial AITD。
  • IPMK、ZFYVE1和METAP2基因机制上参与免疫通路且先前已显示与自身免疫相关。

研究设计与样本

  • 对34个家族性AITD家系中先前定位的3个连锁位点(10q、12q、14q)进行深度测序。

主要发现

  • 鉴定出13个IPMK基因罕见变异与AITD(Graves病和桥本甲状腺炎)相关。
  • 鉴定出2个罕见变异(DLST和ZFYVE1基因内)仅与Graves病相关。
  • 鉴定出3个罕见变异(PGAM1P5、LOC105369879和METAP2基因内)仅与桥本甲状腺炎相关。

临床怎么用

  • 这些基因 predispose to thyroid autoimmunity,未来可能作为潜在治疗靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Genetic risk factors play a major role in the pathoetiology of autoimmune thyroid diseases (AITD). So far, only common risk variants have been identified in AITD susceptibility genes. Recently, rare genetic variants have emerged as important contributors to complex diseases, and we hypothesized that rare variants play a key role in the genetic susceptibility to AITD. OBJECTIVE: We aimed to identify new rare variants that are associated with familial AITD. METHODS: We performed deep sequencing of 3 previously mapped AITD-linked loci (10q, 12q, and 14q) in a dataset of 34 families in which AITD clustered (familial AITD). RESULTS: We identified 13 rare variants, located in the inositol polyphosphate multikinase (IPMK) gene, that were associated with AITD (ie, both Graves' disease [GD] and Hashimoto's thyroiditis [HT]); 2 rare variants, within the dihydrolipoamide S-succinyltransferase (DLST) and zinc-finger FYVE domain-containing protein (ZFYVE1) genes, that were associated with GD only; and 3 rare variants, within the phosphoglycerate mutase 1 pseudogene 5 (PGAM1P5), LOC105369879, and methionine aminopeptidase 2 (METAP2) genes, that were associated with HT only. CONCLUSION: Our study demonstrates that, in addition to common variants, rare variants also contribute to the genetic susceptibility to AITD. We identified new rare variants in 6 AITD susceptibility genes that predispose to familial AITD. Of these, 3 genes, IPMK, ZFYVE1, and METAP2, are mechanistically involved in immune pathways and have been previously shown to be associated with autoimmunity. These genes predispose to thyroid autoimmunity and may serve as potential therapeutic targets in the future.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Li CW, Sachidanandam R, Jayaprakash A, et al. Identification of New Rare Variants Associated With Familial Autoimmune Thyroid Diseases by Deep Sequencing of Linked Loci. J Clin Endocrinol Metab. 2021. PMID: 34143178. doi:10.1210/clinem/dgab440

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。